BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17001317)

  • 1. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.
    Chin SF; Wang Y; Thorne NP; Teschendorff AE; Pinder SE; Vias M; Naderi A; Roberts I; Barbosa-Morais NL; Garcia MJ; Iyer NG; Kranjac T; Robertson JF; Aparicio S; Tavaré S; Ellis I; Brenton JD; Caldas C
    Oncogene; 2007 Mar; 26(13):1959-70. PubMed ID: 17001317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
    Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated profiling of basal and luminal breast cancers.
    Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
    Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.
    Snijders AM; Nowee ME; Fridlyand J; Piek JM; Dorsman JC; Jain AN; Pinkel D; van Diest PJ; Verheijen RH; Albertson DG
    Oncogene; 2003 Jul; 22(27):4281-6. PubMed ID: 12833150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
    Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
    Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas.
    Vékony H; Röser K; Löning T; Ylstra B; Meijer GA; van Wieringen WN; van de Wiel MA; Carvalho B; Kok K; Leemans CR; van der Waal I; Bloemena E
    Genes Chromosomes Cancer; 2009 Feb; 48(2):202-12. PubMed ID: 19009612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer.
    Kimmel RR; Zhao LP; Nguyen D; Lee S; Aronszajn M; Cheng C; Troshin VP; Abrosimov A; Delrow J; Tuttle RM; Tsyb AF; Kopecky KJ; Davis S; Neiman PE
    Radiat Res; 2006 Sep; 166(3):519-31. PubMed ID: 16953671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.
    Rodriguez V; Chen Y; Elkahloun A; Dutra A; Pak E; Chandrasekharappa S
    Genes Chromosomes Cancer; 2007 Jul; 46(7):694-707. PubMed ID: 17440925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
    Marchiò C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
    J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and gene expression profiling of 20q13-amplified breast cancers.
    Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
    Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q.
    Riener MO; Nikolopoulos E; Herr A; Wild PJ; Hausmann M; Wiech T; Orlowska-Volk M; Lassmann S; Walch A; Werner M
    Hum Pathol; 2008 Nov; 39(11):1621-9. PubMed ID: 18656243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.
    Roman E; Meza-Zepeda LA; Kresse SH; Myklebost O; Vasstrand EN; Ibrahim SO
    Oncol Rep; 2008 Oct; 20(4):825-43. PubMed ID: 18813824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of a customized multiple signature microarray for breast cancer.
    Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
    Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.